BubR1 as a Prognostic Marker for Recurrence-Free Survival Rates in Epithelial Ovarian Cancers

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Epithelial Protein Lost in Neoplasm-Α (EPLIN-α) Is a Potential Prognostic Marker for the Progression of Epithelial Ovarian Cancer

International Journal of Oncology
Cancer ResearchOncology
2016English

CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival

American Journal of Pathology
Forensic MedicinePathology
2002English

Prognostic Factors for Recurrence-Free and Overall Survival After Adrenalectomy for Metastatic Carcinoma: A Retrospective Cohort Pilot Study

BMC Urology
MedicineReproductive MedicineUrology
2014English

Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers

Scientific Reports
Multidisciplinary
2014English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

Promoter Hypermethylation in Plasma-Derived Cell-Free DNA as a Prognostic Marker for Pancreatic Adenocarcinoma Staging

International Journal of Cancer
Cancer ResearchOncology
2017English

Fertility Sparing Surgery vs Radical Surgery for Epithelial Ovarian Cancer: A Meta-Analysis of Overall Survival and Disease-Free Survival

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy